Agave BioSystems Scientists and Engineers synergize expertise in electronics, mechanical engineering and biotechnology to develop novel biosensors for field use. Assays for detection of pathogens, nucleic acids or proteins are validated, miniaturized and automated for custom-designed biochips and instruments for environmental biosensor and Point-of-Care diagnostics.
The Agave team has deep experience in developing and validating binding, enzymatic and cell based assays in 96 and 384-well plate formats. Custom genetic and small molecules screens focus on enzyme optimization, diagnostics (Luminex platform), compound discovery, aptamer and PNA development.
Agave BioSystems Scientists and Process Engineers develop industrial enzymes, whole cell sensors and reporter systems by optimizing E. coli, S. cerevisiae, P. pastoris and A. niger to produce bioactive molecules.
Agave BioSystems Team has a versatile expression and purification system for development of novel vaccines. The virus-like particle (VLP) platform is established to present multivalent pathogen epitopes to induce immunogenic responses in vivo.
The Agave BioSystems team applies cutting edge science and commercialization expertise to develop lasting solutions to challenges facing humanity today. Founded in 1998, Agave BioSystems, with research facilities in Ithaca, New York, leverages strong ties with Cornell University.
Our customers experience top research, design, development, and application of biologically derived systems in the field of diagnostics, medical research, environmental sensors, and the discovery and commercialization of bioactive compounds and macromolecules.
Agave BioSystems applies innovative solutions to novel assay development, process optimization, miniaturization, automating and delivering Point-of-Care solutions.
Interested in a job at Agave? Please contact us below for more information about opportunities at Agave.
Please fill out the form below to send us a message.